Danish regulators slam Indian API maker for GMP failings

By Staff Reporter

- Last updated on GMT


Related tags: Danish medicines agency, Pharmaceutical drug, Medicine, Gmp

Kadam Exports Private has received a statement of non-compliance with GMP after the Danish Medicines Agency found manufacturing deficiencies at its facility in Gujarat.

The facility, inspected on December 7 last year by the Danish regulators, received a certificate of non-compliance with Good Manufacturing Practice (GMP) details of which were posted on the EudraGMP website​.

The facility located in Mehsana, in the Gujarat region of India makes the active pharmaceutical ingredient (API) Psyllium HUSK, an herbal product consisting of plant fibres for dietary and herbal medicinal products. According to the Danish Medicines Agency, the product made by Kadam is only used as an API in Denmark.

According to the report, there was a general lack of ability by the firm to adhere to the principles of GMP for production facilities, laboratory facilities and storage of reference and retention samples.

“Examples of non-adherence are: The production facilities were not appropriate for GMP use. There was a big risk of contamination of products. The whole facility was not in a protected and controlled environment,”​ the certificate states.

“Also the laboratory facilities were not in a protected and controlled environment. Reference and retention samples were not stored in a controlled container. The personnel was not trained in EU GMP guidelines. As a result the quality of the product is not ensured.”

As a result of the inspection, Kadam’s certificate No DK API-H 00049515 will not be renewed.

Related news

Show more

Related products

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Related suppliers

Follow us


View more